EMA Authorised: Bronchitol (mannitol) — Pharmaxis Europe Limited

View source ↗

Summary

The EMA authorised Bronchitol (mannitol) for cystic fibrosis, marking EU approval with Pharmaxis Europe Limited as the marketing authorization holder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Bronchitol (mannitol)

Snippet

Status: Authorised. Therapeutic area: Cystic Fibrosis. MAH: Pharmaxis Europe Limited. Decision date: 12/02/2026